The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Open accessAbstract
The success of cancer immunotherapy relies on the knowledge of the tumor microenvironment and the immune evasion mechanisms in which the tumor, stroma, and infiltrating immune cells function in a complex network. The potential barriers that profoundly challenge the overall clinical outcome of promising therapies need to be fully identified and counteracted. Although cancer immunotherapy has increasingly been applied, we are far from understanding how to utilize different strategies in the best way and how to combine therapeutic options to optimize clinical benefit. This review intends to give a contemporary and detailed overview of the different roles of immune cells, exosomes, and molecules acting in the tumor microenvironment and how they relate to immune activation and escape. Further, current and novel immunotherapeutic options will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–274 of 274
Yao, W., He, J., Yang, Y., Wang, J., Qian, Y., Yang, T., & Ji, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-08128-1 · Cited by 151
Miyake, K., Shiozawa, N., Nagao, T., Yoshikawa, S., Yamanishi, Y., & Karasuyama, H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615973114 · Cited by 150
Yang, H., Fu, H., Wang, B., Zhang, X., Mao, J., Li, X., Wang, M., Sun, Z., Qian, H., & Xu, W. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22838 · Cited by 149
Kong, L., Zhou, Y., Bu, H., Lv, T., Shi, Y., & Yang, J. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0412-1 · Cited by 147
The Biology and Functions of Th22 Cells
Jia, L., & Wu, C. Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_8 · Cited by 146
Wang, X., Shen, H., Zhangyuan, G., Huang, R., Zhang, W., He, Q., Jin, K., Zhuo, H., Zhang, Z., Wang, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0180-7 · Cited by 146
Lee, C., Kwak, Y., Yang, T., Han, J. H., Park, S., Ye, M. B., Lee, W., Sim, K.-Y., Kang, J., Kim, Y., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.062 · Cited by 145
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Rocca, Y., Roberti, M. P., Arriaga, J. M., Amat, M., Bruno, L. I., Pampena, M. B., Huertas, E., Loria, F. S., Pairola, A., Bianchini, M., et al. (2012) · Innate Immunity · doi:10.1177/1753425912453187 · Cited by 144
The dark side of tumor-associated endothelial cells
Sanctis, F. D., Ugel, S., Facciponte, J. G., & Facciabene, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.002 · Cited by 143
de Coaña, Y. P., Wolodarski, M., Poschke, I., Yoshimoto, Y., Yang, Y., Nyström, M., Edbäck, U., Brage, S. E., Lundqvist, A., Masucci, G. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15368 · Cited by 139
The cellular biology of eosinophil eicosanoid formation and function
Bandeira‐Melo, C., Bozza, P. T., & Weller, P. F. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121529 · Cited by 138
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
Afferni, C., Buccione, C., Andreone, S., Galdiero, M. R., Varricchi, G., Marone, G., Mattei, F., & Schiavoni, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02601 · Cited by 137
Molecular mechanisms underlying therapeutic potential of pericytes
Harrell, C. R., Marković, B. S., Fellabaum, C., Arsenijević, A., Djonov, V., & Volarević, V. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0423-7 · Cited by 135
Tolerogenic dendritic cells and their applications in transplantation
Li, H., & Shi, B. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.52 · Cited by 132
Opposing roles of eosinophils in cancer
Simon, S. C. S., Utikal, J., & Umansky, V. (2019) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-018-2255-4 · Cited by 128
Human “T H 9” cells are a subpopulation of PPAR-γ + T H 2 cells
Micossé, C., von Meyenn, L., Steck, O., Kipfer, E. T., Adam, C., Simillion, C., Jafari, S. M. S., Oláh, P., Yawalkar, N., Simon, D., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aat5943 · Cited by 126
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis
Eiró, N., González-Llorente, L., Martínez-Ordóñez, A., Fernández‐García, B., González, L. O., Cid, S., Domínguez, F., Pérez-Fernández, R., & Vizoso, F. J. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0371-y · Cited by 125
Kushwah, R., Wu, J., Oliver, J., Jiang, G., Zhang, J., Siminovitch, K. A., & Hu, J. (2010) · European Journal of Immunology · doi:10.1002/eji.200939782 · Cited by 124
Prognostic significance of regulatory T cells in tumor
Wilke, C. M., Wu, K., Zhao, E., Wang, G., & Zou, W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25464 · Cited by 124
RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers
Irshad, S., Flores‐Borja, F., Lawler, K., Monypenny, J., Evans, R., Male, V. H., Gordon, P., Cheung, A., Gazińska, P., Noor, F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0598 · Cited by 122
A short field guide to fibroblast function in immunity
Buechler, M. B., & Turley, S. J. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2017.11.001 · Cited by 121
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Wang, Y., Schafer, C. C., Hough, K. P., Tousif, S., Duncan, S. R., Kearney, J. F., Ponnazhagan, S., Hsu, H., & Deshane, J. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701069 · Cited by 120
Different subsets of natural killer T cells may vary in their roles in health and disease
Kumar, V., & Delovitch, T. L. (2014) · Immunology · doi:10.1111/imm.12247 · Cited by 118
Kelleher, R. J., Balu‐Iyer, S. V., Loyall, J. L., Sacca, A. J., Shenoy, G. N., Peng, P., Iyer, V., Fathallah, A. M., Berenson, C. S., Wallace, P. K., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0086 · Cited by 118
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells
Sektioglu, I. M., Carretero, R., Bulbuc, N., Bald, T., Tüting, T., Rudensky, A. Y., & Hämmerling, G. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0993 · Cited by 116
Cai, Q., Zhu, A., & Gong, L. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2018.05.003 · Cited by 116
Innate effector cells in angiogenesis and lymphangiogenesis
Varricchi, G., Loffredo, S., Galdiero, M. R., Marone, G., Cristinziano, L., Granata, F., & Marone, G. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.002 · Cited by 115
MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer
Schwarzenbach, H., & Gahan, P. B. (2019) · Non-Coding RNA · doi:10.3390/ncrna5010028 · Cited by 110
Jiang, S., Game, D. S., Davies, D. C., Lombardi, G., & Lechler, R. I. (2005) · European Journal of Immunology · doi:10.1002/eji.200425899 · Cited by 108
CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer
Wang, R.-F. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.276 · Cited by 100
Peng, Y., Zhang, J., Liang, W., Tu, M., Lu, Z., Wei, J., Jiang, K., Gao, W., Wu, J., Xu, Z., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-738 · Cited by 98
TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism
Xu, A., Liu, Y., Chen, W., Wang, J., Xue, Y., Huang, F., Rong, L., Lin, J., Liu, D., Yan, M., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501740 · Cited by 98
Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells
Nagaraj, S., & Gabrilovich, D. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.010 · Cited by 96
Jensen, H. K., Donskov, F. N., Nordsmark, M., Marcussen, N., & von der Maase, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1296 · Cited by 96
Labani‐Motlagh, A., Israelsson, P., Ottander, U., Lundin, E., Nagaev, I., Nagaeva, O., Dehlin, E., Baranov, V. I., & Mincheva‐Nilsson, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-4313-2 · Cited by 93
Self-citationBeyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells
Eagle, R. A., Jafferji, I., & Barrow, A. D. (2009) · Current Immunology Reviews · doi:10.2174/157339509787314369 · Cited by 92
Antitumor Activity of Eosinophils Activated by IL-5 and Eotaxin against Hepatocellular Carcinoma
Kataoka, S., Konishi, Y., Nishio, Y., Fujikawa‐Adachi, K., & Tominaga, A. (2004) · DNA and Cell Biology · doi:10.1089/dna.2004.23.549 · Cited by 91
Lindqvist, C. A., Christiansson, L. H., Simonsson, B., Enblad, G., Olsson‐Strömberg, U., & Loskog, A. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03308.x · Cited by 86
Self-citationNonomura, Y., Otsuka, A., Nakashima, C., Seidel, J. A., Kitoh, A., Dainichi, T., Nakajima, S., Sawada, Y., Matsushita, S., Aoki, M., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1248327 · Cited by 83
Tumor-Derived Vascular Pericytes Anergize Th Cells
Bose, A., Barik, S., Banerjee, S., Ghosh, T., Mallick, A., Majumdar, S. B., Goswami, K. K., Bhuniya, A., Banerjee, S., Baral, R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300280 · Cited by 81
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
Martinenaite, E., Ahmad, S. M., Hansen, M., Met, Ö., Westergaard, M. C. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, I. M., & Andersen, M. H. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238541 · Cited by 81
Fionda, C., Malgarini, G., Soriani, A., Zingoni, A., Cecere, F., Iannitto, M. L., Ricciardi, M. R., Federico, V., Petrucci, M. T., Santoni, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201426 · Cited by 78
Mast cells, basophils and B cell connection network
Merluzzi, S., Betto, E., Ceccaroni, A. A., Magris, R., Giunta, M., & Mion, F. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.016 · Cited by 73
Benyahia, Z., Dussault, N., Cayol, M., Sigaud, R., Berenguer‐Daizé, C., Delfino, C., Tounsi, A., Garcia, S., Martin, P., Mabrouk, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14999 · Cited by 71
Christiansson, L. H., Söderlund, S., Mangsbo, S. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0849 · Cited by 70
Glioblastoma‐activated pericytes support tumor growth via immunosuppression
Sena, I. F. G., Paiva, A. E., Prazeres, P. H. D. M., de Azevedo, P. O., Lousado, L., Bhutia, S. K., Salmina, A. B., Mintz, A., & Birbrair, A. (2018) · Cancer Medicine · doi:10.1002/cam4.1375 · Cited by 70
Yamada, N., Yamanegi, K., Ohyama, H., Hata, M., Nakasho, K., Futani, H., Okamura, H., & Terada, N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1630 · Cited by 69
The role of basophils in helminth infection
Voehringer, D. (2009) · Trends in Parasitology · doi:10.1016/j.pt.2009.09.004 · Cited by 69
Borcherding, N. C., Kolb, R. H., Gullicksrud, J. A., Vikas, P., Zhu, Y., & Zhang, W. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.030 · Cited by 68
Larrain, M. T. I., Rabassa, M. E., Lacunza, E., Barbera, A., Cretón, A., Segal‐Eiras, A., & Croce, M. V. (2014) · Tumor Biology · doi:10.1007/s13277-014-1859-3 · Cited by 63
Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
Park, Y.-J., Song, B., Kim, Y.-S., Kim, E., Lee, J.-M., Lee, G.-E., Kim, J., Kim, Y., Chang, W., & Kang, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0545 · Cited by 63
Eosinophils induce DC maturation, regulating immunity
Lotfi, R., & Lotze, M. T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607366 · Cited by 61
Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells
Martin, R., Saleem, S. J., Folgosa, L., Zellner, H. B., Damle, S., Nguyen, G.-K. T., Ryan, J. J., Bear, H. D., Irani, A.-M. A., & Conrad, D. H. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a1213-644r · Cited by 60
Weed, D. T., Zilio, S., dos Reis, I. M., Sargi, Z., Abouyared, M., Gomez-Fernandez, C. R., Civantos, F., Rodriguez, C. P., & Serafini, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01206 · Cited by 60
Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells
Li, L., Tian, H., Chen, Z., Yue, W., Li, S., & Li, W. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq118 · Cited by 59
Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity
Tiwary, S., Berzofsky, J. A., & Terabe, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02187 · Cited by 59
A Fundamental Role of Myh9 for Neutrophil Migration in Innate Immunity
Zehrer, A., Pick, R., Salvermoser, M., Boda, A., Miller, M., Stark, K., Weckbach, L. T., Walzog, B., & Begandt, D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701400 · Cited by 58
Intravesical bacillus Calmette–Guérin instillation in non‐muscle‐invasive bladder cancer: A review
Saluja, M., & Gilling, P. (2017) · International Journal of Urology · doi:10.1111/iju.13410 · Cited by 55
CTL-Derived Exosomes Enhance the Activation of CTLs Stimulated by Low-Affinity Peptides
Wu, S.-W., Li, L., Wang, Y., & Xiao, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01274 · Cited by 55
Regulatory T cells induce activation rather than suppression of human basophils
Sharma, M., Das, M., Victor, E. S., Galeotti, C., Karnam, A., Maddur, M. S., Bruneval, P., Kaveri, S. V., & Bayry, J. (2018) · Science Immunology · doi:10.1126/sciimmunol.aan0829 · Cited by 54
Schiza, A., Wenthe, J., Mangsbo, S. M., Eriksson, E., Nilsson, A., Tötterman, T. H., Loskog, A., & Ullenhag, G. J. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1182-z · Cited by 51
Self-citationPerez, V. L., Henault, L. E., & Lichtman, A. H. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1362 · Cited by 49
Stimulation of Neutrophil Interleukin-8 Production by Eosinophil Granule Major Basic Protein
Page, S. M., Gleich, G. J., Roebuck, K. A., & Thomas, L. L. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.2.3647 · Cited by 48
Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer
Gao, Y., Zhou, S. Y., Xu, Y., Sheng, S., Qian, S. Y., & Huo, X. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.12.008 · Cited by 48
Khan, A. N. H., Emmons, T. R., Wong, J. T., Alqassim, E., Singel, K. L., Mark, J., Smith, B. E., Tario, J. D., Eng, K. H., Moysich, K. B., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0556 · Cited by 46
Donskov, F. N., Bennedsgaard, K. M., Hokland, M., Marcussen, N., Fisker, R. V., Madsen, H. H. T., Fode, K., & von der Maase, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0525-9 · Cited by 42
IDO inhibits T-cell function through suppressing Vav1 expression and activation
Li, R., Wei, F., Yu, J., Li, H., Ren, X., & Ren, X. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.14.8882 · Cited by 41
Hoepner, S., Loh, J. M. S., Riccadonna, C., Derouazi, M., Maroun, C. Y., Dietrich, P., & Walker, P. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063933 · Cited by 40
Zahoor, H., Mir, M. C., Barata, P. C., Stephenson, A. J., Campbell, S. C., Fergany, A. F., Dreicer, R., & Garcia, J. A. (2019) · Investigational New Drugs · doi:10.1007/s10637-018-00716-w · Cited by 39
Quillien, V., Carpentier, A. F., Gey, A., Avril, T., Tartour, É., Sejalon, F., Campillo‐Gimenez, B., & Vauléon, É. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02317-9 · Cited by 34
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
Blom, K., Rubin, J., Berglund, M., Jarvius, M., Lenhammar, L., Parrow, V., Andersson, C. R., Loskog, A., Fryknäs, M., Nygren, P., et al. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4273-5 · Cited by 23
Self-citationLeukotriene D4 Induces Production of Transforming Growth Factor-β1 by Eosinophils
Kato, Y., Fujisawa, T., Nishimori, H., Katsumata, H., Atsuta, J., Iguchi, K., & Kamiya, H. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000085427 · Cited by 21
Imaging natural killer T cells in action
Wong, C. H. Y., & Kubes, P. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.6 · Cited by 20
Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model
Hu, Y., Liu, J., Cui, P., Liu, T., Piao, C., Xu, X., Zhang, Q., Xiao, M., Lu, Y., Liu, X., et al. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.104036 · Cited by 16
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Del Prete, A., Salvi, V., Soriani, A., Laffranchi, M., Sozio, F., Bosisio, D., & Sozzani, S. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00990-6 · Cited by 644
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402
Metadata
- Authors
- Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-15
- Volume
- 11
- Pages
- 940-940
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3025076282
- Cited by
- 751
- References
- 274
- FWCI
- 34.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.